Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas-Reference-Cited by-同舟云学术

Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas

Published:2004 Issue:7 Volume:101 Page:1664-1671
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Casanova Michela,Ferrari Andrea,Bisogno Gianni,Merks Johannes H. M.,De Salvo Gian Luca,Meazza Cristina,Tettoni Katia,Provenzi Massimo,Mazzarino Ida,Carli Modesto

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. Biology and therapy of pediatric rhabdomyosarcoma.

2. Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V

3. High-Dose Melphalan With Autologous Stem-Cell Rescue in Metastatic Rhabdomyosarcoma

4. Vinorelbine in previously treated advanced childhood sarcomas

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrative morpho-molecular approach in malignant ectomesenchymoma diagnosis: report of a new paediatric case and a review of the literature;Frontiers in Oncology;2024-03-01

2. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancers;2024-02-29

3. Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response;International Journal of Molecular Sciences;2024-02-28

4. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC);Pathology - Research and Practice;2024-01

5. Maintenance Chemotherapy for Patients with Rhabdomyosarcoma;Cancers;2023-08-07